(19)
(11) EP 4 823 635 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24833515.0

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
A61K 51/04(2006.01)
A61K 103/00(2006.01)
A61K 101/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 51/0497; A61K 51/0455; A61K 51/0402
(86) International application number:
PCT/EP2024/086334
(87) International publication number:
WO 2025/125621 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.12.2023 DE 102023135236
21.12.2023 DE 102023136424
03.01.2024 DE 102024100145
04.01.2024 DE 102024100225
06.01.2024 DE 102024100299
21.01.2024 DE 102024101650
04.02.2024 DE 102024103063
30.06.2024 DE 102024118480

(71) Applicant: Scifortech GmbH
65189 Wiesbaden (DE)

(72) Inventor:
  • ZOUNEK, Alexis Nikolai
    65187 Wiesbaden (DE)

(74) Representative: Tergau & Walkenhorst Intellectual Property GmbH 
Lurgiallee 12
60439 Frankfurt am Main
60439 Frankfurt am Main (DE)

   


(54) CANCER-ASSOCIATED PROTEIN-TARGETED STRONG OR COVALENTLY BINDING PRECURSOR COMPOUNDS AND RADIOTRACERS